Capital raises and the dilution they cause are a frequent source of board and shareholder disputes, particularly where existing holders believe an issue was priced low, structured to favour insiders, or used to shift control. They matter because directors authorising an issue owe duties to act for proper purposes and even-handedly, and a contested raise can attract oppression claims, injunctions and regulatory scrutiny while the company most needs funding. This report explains how dilution disputes arise in your chosen jurisdiction and industry, the pre-emption, proper-purpose and approval frameworks that apply, the warning indicators of a contentious issue, the impact ranges, the controls that make a raise defensible, and when to engage corporate counsel, independent directors and valuation experts in structuring a capital raise.
Reference material for informed readers, not advice.
